moxeza

Moxifloxacin (Avelox) is a fourth-generation fluoroquinolone that has been shown to be effective against Gram-positive, Gram-negative, and atypical strains, as well as multi-drug resistant Streptococcus pneumoniae.

Moxifloxacin-d4 HCl is a deuterated compound of Moxifloxacin HCl. Moxifloxacin HCl has a CAS number of 186826-86-8. Moxifloxacin is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Moxifloxacin has been linked to mild ALT elevations during therapy and to rare instances of idiosyncratic acute liver injury with symptoms and jaundice.

Moxifloxacin-13C-d3 the 13C and deuterated compound of Moxifloxacin. Moxifloxacin has a CAS number of 151096-09-2. Moxifloxacin is a fourth-generation fluoroquinolone that has been shown to be effective against Gram-positive, Gram-negative, and atypical strains, as well as multi-drug resistant Streptococcus pneumoniae.

Moxifloxacin, Hydrochloride Monohydrate is a useful organic compound for research related to life sciences. The catalog number is T66125 and the CAS number is 192927-63-2.

Moxifloxacin-d4 is a deuterated compound of Moxifloxacin. Moxifloxacin has a CAS number of 151096-09-2. Moxifloxacin is a fourth-generation fluoroquinolone that has been shown to be effective against Gram-positive, Gram-negative, and atypical strains, as well as multi-drug resistant Streptococcus pneumoniae.

Moxifloxacin hydrochloride (BAY12-8039 HCl) is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Moxifloxacin has been linked to mild ALT elevations during therapy and to rare instances of idiosyncratic acute liver injury with symptoms and jaundice.